MAP7D3 (MAP7 domain containing 3) is an X-linked gene encoding a microtubule-associated protein that promotes microtubule assembly and stability. MAP7D3 functions as a kinesin-1 activator by binding to both kinesin-1 motors and microtubules, facilitating motor recruitment and increasing microtubule landing rate and processivity 1. Compared to its paralog MAP7, MAP7D3 exhibits higher affinity for kinesin-1 and lower affinity for microtubules, enabling cotransport with the motor 1. Disease relevance spans neurodevelopmental and reproductive disorders. A novel frameshift mutation (c.2174_2177del) in MAP7D3 was identified in two siblings with severe intellectual disability and autistic traits, with 3D modeling suggesting the variant destabilizes the protein's C-terminal tail and impairs kinesin-1 binding 2. MAP7D3 variants are associated with male infertility: truncating variants were found in an asthenozoospermic patient affecting sperm capacitation 3, and low-frequency variants were identified in nonobstructive azoospermia cases, with knockdown studies showing impaired spermatogonial stem cell function 45. Clinically, MAP7D3 has emerged as a prognostic biomarker in pediatric Wilms tumor 6 and prostate adenocarcinoma 7, with elevated expression correlating with poorer prognosis and altered immunotherapy response in prostate cancer.